First Treatment for Children With Rare Myasthenic Syndrome

Amifampridine tablets have receivedapproval for treating children aged 6 to 17 years who have Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disease that causes debilitating muscle weakness.
Source: JAMA - Category: General Medicine Source Type: research